Aim: To quantitatively analyse factors related to gastrointestinal bleeding after percutaneous coronary intervention and provide evidence for the prevention of gastrointestinal bleeding.
• Other factors which should be taken into consideration include general demographic and disease risk factors.
The implications of this paper:
• Findings can be used as a reference to help prevent potentially fatal complications after percutaneous coronary intervention.
| INTRODUCTION
Percutaneous coronary intervention (PCI) is one of the most effective treatments for coronary artery syndrome, and postoperative complication management is an important part of the PCI therapy. Gastrointestinal bleeding (GIB) is an important complication after PCI. Several studies have shown that incidence of GIB in patients undergoing PCI ranges from 0.4% to 4.3% (Nadatani et al., 2013; Tanigawa et al., 2011; Toyokawa et al., 2010; Nikolsky, Mehran, & Stone, 2009; Ng et al., 2008) . Major bleeding can reduce blood volume, increase heart rate, and decrease myocardial perfusion, so antiplatelet therapies have to be changed after bleeding.
However, changing the treatment regimen may in turn increase the probability of myocardial infarction (1.3%), stent thrombosis (5.8%), and hospitalization duration (12%) , and was associated with in-hospital mortality increase from 7.9% in 2006 to 10.78% in 2012 (Patel et al., 2016) . Therefore, it is very important to reduce the incidence of GIB for patient recovery. Studying and screening for GIB risk and protective factors will help realize postoperative personalized monitoring and prediction of high-risk patients and lead to improvements in postoperative management systems. Patient outcomes will improve if early intervention occurs in cases of GIB.
Systematic review and meta-analysis is a research method which is part of the evidence-based practice model used to explore clinical problems. This study aimed to conduct an updated and comprehensive systematic review and meta-analysis through an extensive search of observational studies, and quantitatively analyse factors related to GIB so as to provide accurate evidence for its prevention. (Moher, Liberati, Tetzlaff, & Altman, 2009) . Research reports in English were identified from the Cochrane Library, Pubmed, Embase, and Ovid databases from inception to 31 May 2018, as well as a review of reference lists of eligible studies (Figure 1 ). The search terms included "PCI," "percutaneous coronary intervention," "balloon angioplasty," "stent implantation," "percutaneous transluminal coronary angioplasty," "PTCA," "gastrointestinal bleeding," "haemorrhage/haemorrhage," "risk factors," "protective factors," "factors," "predictors."
| Inclusion criteria
(1) Population: patients after PCI; (2) Outcome: risk factors and protective factors for GIB after PCI; (3) Study type: Cohort or casecontrol studies; (4) Data type: studies reporting odds ratio (OR), hazard ratio (HR), relative risk (RR), standard error (SE), β, and 95% confidence interval (CI) representing factors in relation to developing GIB.
| Exclusion criteria
Studies with the following limitations were excluded: (1) where one factor was reported repeatedly in the same study population; (2) reported measures other than OR, RR, or equivalent values, or from which an OR could not be calculated.
| Data extraction
Data were extracted from the included studies and entered into a standardized data collection form. Study and patient characteristics FIGURE 1 Flow diagram of study selection were as follows: authors, year of publication, country, study type, sample size, and factors for GIB after PCI. Data were extracted by a single reviewer, then independently checked for completeness and accuracy by a second reviewer. Whenever necessary, the authors were contacted to clarify important data involved in the review. Full details of the 16 included studies are provided in Table 1 .
| Quality assessment
Two review authors independently estimated study quality using the Newcastle-Ottawa Scale (Wells et al., 2000) . The tool consists of three factors: patient selection (4 items), comparability of the study groups (1 item), and assessment of outcome/exposure (3 items). A score of 0 to 9 (allocated as stars) was allocated to observational studies. Each cohort or case-control study achieving six or more stars was considered high quality. Disagreements were settled down through discussion among authors.
2.6 | Statistical analysis 2.6.1 | Data synthesis and analysis A meta-analysis was conducted to determine the pooled factors of GIB after PCI. Statistical analyses were done using Revman version 5.3. Data were analysed by generic inverse variance to generate a pooled effect size and 95% confidence interval (CI). Hazard ratio (HR), odds ratio (OR), and risk ratio (RR) values were synthesized if the value was less than 5%. If the result was β and SE, then the effect size (ES) = lnOR = β, SE = (ln upper CI-ln low CI) /3.92; if the literature had only OR or β and the exact P value, then the standard normal distribution curve under the P value corresponding to the normal deviation Zp needed to be identified, and SE = (lnOR)/Zp = β/Zp. When studies reported both the crude OR/RR/HR and the adjusted OR/RR/HR, the adjusted figures were chosen.
Heterogeneity across studies was examined the I 2 statistic (Dersimonian & Laird, 1986; Higgins, Thompson, Deeks, & Altman, 2003) . If statistically significant heterogeneity was found when using the fixed effects model, the reasons for the significant heterogeneity were identified and analysed and sensitivity analysis, sub-group analysis, and regression analysis were undertaken. According to Cochrane
Handbook 5.3, values of I 2 ranging from 0% to 60% may represent moderate heterogeneity, and heterogeneity within the controllable range. When statistically significant heterogeneity was still found (P < 0.05 and I 2 > 60%), a random effects model was used to provide the most conservative estimate.
| Publication bias
Publication bias was assessed by visual assessment of asymmetry of the funnel plot (Higgins & Green, 2011) , and the Begg Rank Correlation Test (Begg & Mazumdar, 1994) was performed for metaanalyses with less than 10 studies. Statistical analyses were done using Stata statistical software version 11.0 (StataCorp, College Station, TX). The specific adjustment data were not presented in the original literature.
b Adjusted for age, sex, low income, comorbid conditions, and medication use.
c Adjusted for age and sex.
d Adjusted for age and sex.
3 | RESULTS
| Identification of studies
A total of 5734 articles were identified, and 5578 studies were excluded as being duplications or irrelevant. Potentially eligible articles (total = 174) were selected. A full-text review of the articles yielded 16 studies meeting the inclusion criteria for a total of 5 695 188 patients, of whom 50 795 had undergone GIB after PCI. The studies comprised five case-control studies and 11 cohort studies (Figure 1 ).
| Risk of bias within studies
The risk of bias according to the Newcastle-Ottawa scale (Wells, 2000) is shown in Tables 2 and 3 . The scores range between 7 and 9, indicating high quality.
| Assessment of publication bias
In this review, the use of funnel plots was limited due to the small number of studies evaluated. Therefore, Begg's Test was provided to assess the publication bias. It was found that all of the results indicated insignificant publication bias for all estimates (all P > 0.05) as shown in Table 4 .
| Risk factors of GIB after PCI
Six general demographic risk factors, including age older than 70 years, age (per 10-year increase), female sex, baseline anaemia, history of smoking, and history of using alcohol, were positively associated with GIB. The heterogeneity was within the controllable range (Figure 2 ).
Five disease risk factors, including history of peptic ulcer disease, chronic renal failure, previous bleeding, shock, congestive heart failure, and acute myocardial infarction, were positively associated with GIB ( Figure 3) . The results of this analysis showed significant heterogeneity for acute myocardial infarction (P < 0.00001, I 2 = 98%). Sensitivity test found acute myocardial infarction (P = 0.89, I 2 = 0%) when Shivaraju's study was removed. The reason for the heterogeneity was that the database collected by Shivaraju and Patel was the same.
Data for both were obtained from the Nationwide Inpatient Sample.
The time frame when Shivaraju collected data was 1998 to 2006
and for Patel was 2006 to 2012. Considerations were that the study population was in the same location and some patients may have repeated procedures. We retained Patel's study as the time period for this research was closer to the other two studies. A fixed-effects model should be used when the number of studies included in a meta-analysis is less than five (Tufanaru, Munn, Stephenson, & Aromataris, 2015) . There was no heterogeneity in acute myocardial infarction (P < 0.00001, I 2 = 0%).
Two medicine-related risk factors, including prior use of inotropic medications and prior use of antithrombotic medications, were A star represents one score. 
| Protective factors of GIB after PCI
Two protective medicine-related factors, including proton-pump inhibitor (PPI) therapy and bivalirudin therapy, were negatively associated with GIB. PPI (P < 0.00001, I 2 = 62%) was heterogeneous. Sensitivity test found PPI (P < 0.00001, I 2 = 0%) when Zhang's study was removed. The reason for the heterogeneity was that Zhang's study had restrictions on the target group who took dual antiplatelet therapy after percutaneous coronary intervention. However, there was no such restriction in the other two studies. Therefore, the duration in which patients take anticoagulants may be a confounding factor that needs further exploration, and the study was removed ( Figure 5 ).
| DISCUSSION
This study identified 16 individual factors that had potential value in control of GIB after PCI. The identified risk factors included general demographic characteristics, disease factors, and medicine-related factors, and protective factors only include medicine-related factors.
| General demographic risk factors
Age more than 70 years, age (per 10-year increase), female sex, baseline anaemia, history of smoking, and history of using alcohol were common risk factors. Three studies (Chin, Yong, Bulsara, Rankin, & Forbes, 2007; Patel et al., 2016) found that advanced age but not more than 70-year-old also accompanied risk of gastrointestinal bleeding. In addition, the risk of smoking and alcohol FIGURE 2 Forest plots of odds ratio (OR) with 95% confidence interval (CI) for the general demographic risk factors of GIB after PCI in a fixedeffects model consumption leading to GIB was also proportional to age (Tabiri, Akanbong, & Abubakari, 2016) . Women have been shown to have a near two-fold increase in bleeding complications compared with men after PCI (Ng et al., 2015) and worse outcomes including mortality (Feit et al., 2007) , consistent with the conclusions of this review. It is important to have a comprehensive understanding of these factors, so as to supported initiation of preventive action.
| Disease risk factors
In this meta-analysis, many diseases are associated with GIB. As shown above, gastrointestinal diseases are associated with smoking and drinking. Chronic renal failure is one of the causes of anaemia, with findings by Girndt (2017) in line with this view. This study found kidney disease induced typical sequelae such as left ventricular hypertrophy, vascular calcification, and anaemia. As to congestive heart failure, right heart failure affects the circulation of venous blood back to the heart, causing venous congestion. With portal vein and gastric vein congestion, upper gastrointestinal bleeding appears. Three studies reported previous bleeding was positively significantly associated with GIB (Jiang et al., 2013; Kikkert et al., 2015; Ko et al., 2010) , leading mainly to rebleeding.
| Medicine-related risk factors and protective factors
Use of antithrombotic medications is necessary after PCI. As Nadatani et al. (2013) showed, patients undergoing coronary artery stent FIGURE 3 Forest plots of odds ratio (OR) with 95% confidence interval (CI) for the disease risk factors of GIB after PCI in a fixed-effects model placement require long-term administration of two or more antithrombotic agents. These agents are used as adjunctive therapy to reduce the risk of ischaemic complications such as in-stent restenosis and stent thrombosis. Therefore, the effects of such drugs on GIB are also a focus of attention currently. Many scholars find that antiplatelet therapy may be associated with the risk of gastrointestinal bleeding (Bhatt et al., 2008) . The incidence of GIB in patients undergoing lowdose aspirin therapy following PCI is high (Nadatani et al., 2013) . However, some studies indicate that low-dose acetylsalicylic acid use prior to PCI did not influence the number or type of risk factors. However, the proportion of patients on low-dose acetylsalicylic acid treatment increases with age (Jensen et al., 2015) . This meta-analysis indicated that NSAID therapy was a risk factor and that the incidence of GIB increased as people became older. As to the risk of glycoprotein IIb/IIIa receptor inhibition, some research found that haemostatic disorders associated with renal insufficiency were attributed mainly to reduced platelet aggregation (Liani, Salvati, Golato, & Tresca, 1996; Pinkau et al., 2008) .
Medical practitioners often use PPI therapy to reduce the risk of GIB. This meta-analysis supports that PPI is a protective factor of GIB after PCI, and this conclusion is consistent with other studies. Previous trials have demonstrated the efficacy of PPIs with low-dose aspirin in secondary prevention of GIB in other high-risk cohorts (Chan et al., 2005; Lai et al., 2002) . Omeprazole was seen to reduce rates of composite upper GI events (1.1% vs 2.9%; P < 0.001) . However, some studies suggest that new formulations of aspirin may limit GI toxicity Whellan et al., 2014) , and enteric-coating may decrease dyspepsia and, as such, have led to underestimation of omeprazole's potential benefits (Vaduganathan et al., 2016) . In the current research, bivalirudin was associated with reduced bleeding, and several publications support this result. Lindsey's research demonstrated that bivalirudin was associated with reduced major and minor bleeding (any: 17.3% vs 31.2%, P < 0.001; major: 1.2% vs 3.0%, P = 0.03; minor: 16.1% vs 28.2%, P < 0.01) without a significant increase in hospital costs compared with other anticoagulation regimens (Lindsey et al., 2010) . In contrast, bivalirudin remained associated with less bleeding risk but higher stent thrombosis risk (Perez et al., 2016) .
While men and women were seen to experience similar safety benefits of bivalirudin therapy in reducing bleeding complications, women experienced a more pronounced benefit of bivalirudin in reducing 12-month mortality than men, so selective bivalirudin therapy may offer the best therapeutic option for women (Ng et al., 2015) .
FIGURE 4
Forest plots of odds ratio (OR) with 95% confidence interval (CI) for the medicine risk factors of GIB after PCI in a fixed-effects model FIGURE 5 Forest plots of odds ratio (OR) with 95% confidence interval (CI) for the protective factors of GIB after PCI in a fixed-effects model
| Strengths and limitations
Previous meta-analyses mainly included randomized controlled trials only exploring single factors in relation to GIB after PCI and have neglected cohort and case-control publications' outcomes. As a result, this research can address this deficit and be combined with previous system reviews and meta-analyses to further demonstrate the reliability of the conclusions.
Limitations in this meta-analysis should be mentioned. First, whilst the analysis of all literature related to multivariate analyses, not all studies listed adjusted risk factors. Therefore, these conclusions should be regarded with caution and indicate areas where future research should concentrate. Second, the studies included in this analysis were not sufficient, especially in terms of subgroup analysis. Potential publication bias is a real risk, despite lack of evidence from the relevant statistical tests. Third, studies were limited to English language, which may result in potential language bias.
Finally, there may be other risk and protective factors that are yet to be explored.
| CONCLUSION
This study is the first systematic review and meta-analysis to evaluate risk and protective factors for GIB after PCI using cohort and case-control studies. The results of this study can contribute significantly to clinical practice. Firstly, it can help clinicians to pay close attention to high-risk groups where GIB may be more likely after PCI. Secondly, for some adverse habits that cause gastrointestinal bleeding, effective health education can be conducted, for example, to educate people to quit smoking and alcohol. Thirdly, findings can assist nurses to provide more targeted care and interventions.
Overall, study findings can assist in the management of this potentially fatal complication.
